Omega-6 and omega-3 polyunsaturated fatty acid levels are reduced in whole blood of Italian patients with a recent myocardial infarction: the AGE-IM study


      • AGE-IM is a case-control study carried out on an Italian cohort.
      • Total PUFA, omega-6 and omega-3 PUFA were reduced in MI patients.
      • MI risk significantly and steadily decreased with increasing levels of PUFA.
      • Both omega-6 and omega-3 were related to MI risk reduction.



      The relationship between whole blood fatty acids and myocardial infarction (MI) risk has not been analyzed in detail, especially in Mediterranean countries. The AGE-IM (Acidi Grassi Essenziali e Infarto Miocardico) study was planned to examine the relationships between MI, whole blood fatty acids and the diet in an Italian cohort.


      119 Patients with a recent MI and 103 control subjects were enrolled in the study. The whole blood fatty acid composition was determined; information on anthropometrics, biochemical parameters and blood pressure values were also obtained. Diet composition was assessed using a validated food frequency questionnaire from 86 cases and 72 controls.


      Total PUFA, omega-6 and omega-3 PUFA (as percentage of whole blood fatty acids) were significantly lower in MI patients than in matched controls, whereas saturated and monounsaturated fatty acids were higher in cases. MI infarction risk significantly and steadily decreased with increasing levels of total PUFA (OR: 0.14) and of total omega-6 and omega-3 (OR: 0.15 and 0.37, respectively). No correlation was identified between dietary fats and MI risk or between whole blood fatty acid levels and dietary nutrients and fats.


      Percentage levels of total PUFA, total omega-3 PUFA and total omega-6 PUFA are lower in MI patients than in matched control subjects in the AGE-IM cohort. These data support a favorable association not only of whole blood percentage levels of total omega-3, but also of total omega-6, with cardiovascular risk.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Willett W.C.
        Dietary fats and coronary heart disease.
        J Intern Med. 2012; 272: 13-24
        • Brouwer I.A.
        • Wanders A.J.
        • Katan M.B.
        Trans fatty acids and cardiovascular health: research completed?.
        Eur J Clin Nutr. 2013; 67: 541-547
        • Mozaffarian D.
        • Micha R.
        • Wallace S.
        Effects on coronary heart disease of increasing polyunsaturated fat in place of saturated fat: a systematic review and meta-analysis of randomized controlled trials.
        PLoS Med. 2010 Mar 23; 7: e1000252
        • Mozaffarian D.
        • Clarke R.
        Quantitative effects on cardiovascular risk factors and coronary heart disease risk of replacing partially hydrogenated vegetable oils with other fats and oils.
        Eur J Clin Nutr. 2009; 63: S22-S33
        • Willett W.C.
        The role of dietary n-6 fatty acids in the prevention of cardiovascular disease.
        J Cardiovasc Med (Hagerstown). 2007; 8: S42-S45
        • De Caterina R.
        n-3 fatty acids in cardiovascular disease.
        N Engl J Med. 2011; 364: 2439-2450
        • Calder P.C.
        n-3 Fatty acids and cardiovascular disease: evidence explained and mechanisms explored.
        Clin Sci (Lond). 2004; 107: 1-11
        • Kromhout D.
        • Yasuda S.
        • Geleijnse J.M.
        • Shimokawa H.
        Fish oil and omega-3 fatty acids in cardiovascular disease: do they really work?.
        Eur Heart J. 2012; 33: 436-443
        • Mensink R.P.
        • Zock P.L.
        • Kester A.D.
        • Katan M.B.
        Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials.
        Am J Clin Nutr. 2003; 77: 1146-1155
        • Ramsden C.E.
        • Hibbeln J.R.
        • Majchrzak S.F.
        • Davis J.M.
        n-6 fatty acid-specific and mixed polyunsaturate dietary interventions have different effects on CHD risk: a meta-analysis of randomised controlled trials.
        Br J Nutr. 2010; 104: 1586-1600
        • Arterburn L.M.
        • Hall E.B.
        • Oken H.
        Distribution, interconversion, and dose response of n-3 fatty acids in humans.
        Am J Clin Nutr. 2006; 83: 1467S-1476S
        • Spector A.A.
        Essentiality of fatty acids.
        Lipids. 1999; 34: S1-S3
        • Harris W.S.
        The omega-6/omega-3 ratio and cardiovascular disease risk: uses and abuses.
        Curr Atheroscler Rep. 2006; 8: 453-459
      1. Joint FAO/WHO Expert Consultation on Fats and Fatty Acids in Human Nutrition. WHO, Geneva10–14 November, 2008
        • Patel P.S.
        • Sharp S.J.
        • Jansen E.
        • et al.
        Fatty acids measured in plasma and erythrocyte-membrane phospholipids and derived by food-frequency questionnaire and the risk of new-onset type 2 diabetes: a pilot study in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Norfolk cohort.
        Am J Clin Nutr. 2010; 92: 1214-1222
        • Ariño A.
        • Beltràn J.A.
        • Herrera A.
        • Roncales P.
        in: Enc Human Nutr. Elsevier Ltd., pp2005: 247-256
        • Simopoulos A.P.
        Genetic variants in the metabolism of omega-6 and omega-3 fatty acids: their role in the determination of nutritional requirements and chronic disease risk.
        Exp Biol Med (Maywood). 2010 Jul; 235: 785-795
        • Marangoni F.
        • Colombo C.
        • Galli C.
        A method for the direct evaluation of the fatty acid status in a drop of blood from a fingertip in humans: applicability to nutritional and epidemiological studies.
        Anal Biochem. 2004; 326: 267-272
        • Risé P.
        • Eligini S.
        • Ghezzi S.
        • et al.
        Fatty acid composition of plasma, blood cells and whole blood: relevance for the assessment of the fatty acid status in humans.
        Prostaglandins Leukot Essent Fatty Acids. 2007; 76: 363-369
        • Harris W.S.
        • Von Schacky C.
        The omega-3 index: a new risk factor for death from coronary heart disease?.
        Prev Med. 2004; 39: 212-220
        • Imamura F.
        • Lemaitre R.N.
        • King I.B.
        • et al.
        Long-chain monounsaturated Fatty acids and incidence of congestive heart failure in 2 prospective cohorts.
        Circulation. 2013; 127 (1521e1–18): 1512-1521
        • Block R.C.
        • Harris W.S.
        • Reid K.J.
        • Spertus J.A.
        Omega-6 and trans fatty acids in blood cell membranes: a risk factor for acute coronary syndromes?.
        Am Heart J. 2008; 156: 1117-1123
        • Marangoni F.
        • Colombo C.
        • Martiello A.
        • et al.
        The fatty acid profiles in a drop of blood from a fingertip correlate with physiological, dietary and lifestyle parameters in volunteers.
        Prostaglandins Leukot Essent Fatty Acids. 2007; 76: 87-92
        • Pala V.
        • Sieri S.
        • Palli D.
        • et al.
        Diet in the Italian EPIC cohorts: presentation of data and methodological issues.
        Tumori. 2003; 89: 594-607
        • Jakobsen M.U.
        • O'Reilly E.J.
        • Heitmann B.L.
        • et al.
        Major types of dietary fat and risk of coronary heart disease: a pooled analysis of 11 cohort studies.
        Am J Clin Nutr. 2009; 89: 1425-1432
        • Khaw K.T.
        • Friesen M.D.
        • Riboli E.
        • et al.
        Plasma phospholipid fatty acid concentration and incident coronary heart disease in men and women: the EPIC-Norfolk prospective study.
        PLoS Med. 2012; 9: e1001255
        • Mozaffarian D.
        • Lemaitre R.N.
        • King I.B.
        • et al.
        Plasma phospholipid long-chain ω-3 fatty acids and total and cause-specific mortality in older adults: a cohort study.
        Ann Intern Med. 2013; 158: 515-525
        • Czernichow S.
        • Thomas D.
        • Bruckert E.
        n-6 Fatty acids and cardiovascular health: a review of the evidence for dietary intake recommendations.
        Br J Nutr. 2010; 104: 788-796
        • Harris W.S.
        • Mozaffarian D.
        • Rimm E.
        • et al.
        Omega-6 fatty acids and risk for cardiovascular disease: a science advisory from the American Heart Association Nutrition Subcommittee of the Council on Nutrition, Physical Activity, and Metabolism; Council on Cardiovascular Nursing; and Council on Epidemiology and Prevention.
        Circulation. 2009; 119: 902-907
        • Sette S.
        • Le Donne C.
        • Piccinelli R.
        • et al.
        The third Italian National Food Consumption Survey, INRAN-SCAI 2005-06 – part 1: nutrient intakes in Italy.
        Nutr Metab Cardiovasc Dis. 2011; 21: 922-932
        • Freisling H.
        • Fahey M.T.
        • Moskal A.
        • et al.
        Region-specific nutrient intake patterns exhibit a geographical gradient within and between European countries.
        J Nutr. 2010; 140: 1280-1286
        • Sofi F.
        • Innocenti G.
        • Dini C.
        • et al.
        Low adherence of a clinically healthy Italian population to nutritional recommendations for primary prevention of chronic diseases.
        Nutr Metab Cardiovasc Dis. 2006; 16: 436-444